Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
ter Heine R, Lange R, Breukels OB, Bloemendal HJ, Rummenie RG, Wakker AM, de Graaf H, Beekman FJ, van der Westerlaken MM, Malingré MM, Wielders JP, van den Berg L, Hendrikse NH, de Klerk JM. ter Heine R, et al. Among authors: hendrikse nh. Int J Pharm. 2014 Apr 25;465(1-2):317-24. doi: 10.1016/j.ijpharm.2014.01.034. Epub 2014 Feb 19. Int J Pharm. 2014. PMID: 24560635
Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical 188Rhenium-HEDP.
Lange R, de Klerk JMH, Bloemendal HJ, Ramakers RM, Beekman FJ, van der Westerlaken MML, Hendrikse NH, Ter Heine R. Lange R, et al. Among authors: hendrikse nh. Nucl Med Biol. 2015 May;42(5):465-469. doi: 10.1016/j.nucmedbio.2015.01.007. Epub 2015 Jan 22. Nucl Med Biol. 2015. PMID: 25662844
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
Lange R, Overbeek F, de Klerk JM, Pasker-de Jong PC, van den Berk AM, Ter Heine R, Rodenburg CJ, Kooistra A, Hendrikse NH, Bloemendal HJ. Lange R, et al. Among authors: hendrikse nh. Nuklearmedizin. 2016 Sep 26;55(5):188-95. doi: 10.3413/Nukmed-0828-16-05. Epub 2016 Jul 22. Nuklearmedizin. 2016. PMID: 27443809 Clinical Trial.
Reply: Quantification of 18F-DCFPyL Uptake: TBR Versus Patlak's Analysis.
Jansen BHE, Yaqub M, Cysouw MCF, Vis AN, van Moorselaar RJA, Hendrikse NH, Hoekstra OS, Boellaard R, Oprea-Lager DE. Jansen BHE, et al. Among authors: hendrikse nh. J Nucl Med. 2019 Dec;60(12):1834-1835. doi: 10.2967/jnumed.119.234047. Epub 2019 Aug 26. J Nucl Med. 2019. PMID: 31451491 Free article. No abstract available.
Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.
Bodar YJL, Veerman H, Meijer D, de Bie K, van Leeuwen PJ, Donswijk ML, van Moorselaar RJA, Hendrikse NH, Boellaard R, Oprea-Lager DE, Vis AN. Bodar YJL, et al. Among authors: hendrikse nh. BJU Int. 2022 Jun;129(6):768-776. doi: 10.1111/bju.15710. Epub 2022 Mar 12. BJU Int. 2022. PMID: 35166426 Free PMC article.
103 results